| abstract |
The present invention concerns a compound having the following formula (I): wherein: - A is in particular -N(R' a )-C(=O)-R, R' a being H or a (C 1 -C 6 )alkyl group, and R being preferably a group having the following formula (II): - X is in particular chosen from the group consisting of: -SO 2 -N(R' b )-, R' b being H or a (C 1 -C 6 )alkyl group, -N(R" b )-SO 2 -, R"b being H or a (C 1 -C 6 )alkyl group, -CO-NH-, and -NH-CO-, for use for the treatment of pathologies characterized by bronchoconstriction, such as asthma. |